OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources

Survival rates for endometrial cancer

Last Modified: December 19, 2004

Question

Dear OncoLink "Ask The Experts,"

My sister-in law was just diagnosed with endometrial cancer. She is having a CT, MRI, colonoscopy, hysterectomy and staging this week. The current rate of survival for stages 1-4 are not clear. I would just like an honest answer so that I can plan the direction of support for my family once she is staged.

Thank you for your time and help.

 

Answer

Christina S. Chu, MD, Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:

It is difficult to find survival rates for various stages of endometrial cancer because the rates vary widely depending on many factors, such as grade of the tumor, substage (IA, IB, or IC, etc.), and histologic subtype (endometrioid versus papillary serous versus clear cell, etc.). Also keep in mind that while a patient with a significant amount of tumor outside of the uterus covering the ovaries and other pelvic structures may be classified as a stage IIIA, a patient with a small amount of tumor confined to the uterus with microscopic spread to the lymph nodes may have a much smaller disease burden overall, but be classified as a stage IIIC, a "higher" stage.

When looking at large numbers of patients with endometrial cancer by stage alone, approximate 5-year survival rates (the percentage of patients alive 5 years after diagnosis) are as follows:

Stage I85%
Stage II65%
Stage III45%
Stage IV15%

Survival for any individual patient may be higher or lower depending on factors specific to their situation. I would encourage you and your family to speak in detail with your physician regarding your sister-in-law's situation, rather than relying on these very general numbers.

OncoLink I wish u knew...

Dr. Rustgi discusses genomics and cancer and translating laboratory research into clinical practice. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS